EQUITY.GURU podcast - Investing for millennials and madmen
Business:Investing
Developing new prescription medicine for market is a costly and oftentimes, a futile endeavor as drugmakers can spend up to $2.6 billion only to see 12% of their candidates gain approval. When Pfizer fails on two out of three new drugs, retail investors have grown leery of the space, but companies like Aequus Pharmaceuticals (AQS.V) have found a way to bypass this massive regulatory and financial bottleneck by seeking out existing drugs approved in other countries and bringing them to Canada for market approval.
Spending 12-18 months rather than the standard 8-10 years for new drug approval, Aequus also benefits from low fixed costs that allow the company to profitably operate in a relatively small marketplace such as Canada in niche areas including neurology, ophthalmology and transplant. Positioned for growth with $2.0 million cash in the till, Aequus is a steady bet in an uncertain industry. As such, Equity Guru’s own Chris Parry spoke with company CEO and chairman, Doug Janzen, to get a better look at Aequus unique de-risked approach and its potential for investors. Tune in!
Short and Sweet (Ep 1) Brigadier Gold (BRG.V), PredictMedix (PMED.C), EarthRenew (ERTH.C) - The Jody Vance Experience
Aequus Pharmaceuticals (AQS.V) CEO, Doug Janzen - EG Interview Highlights
Aequus Pharmaceuticals (AQS.V) CEO, Doug Janzen - EG Interview Part 2
Sixth Wave Innovations (SIXW.C) Equity Guru Zoom Interview Part 2
Sixth Wave Innovations (SIXW.C) Equity Guru Zoom Interview Part 1
Pure Extracts Technologies (PULL.C) CEO explains extraction potential in multiple markets (Part 2)
Pure Extracts Technologies (PULL.C) CEO explains extraction potential in multiple markets (Part 1)
KWESST Micro Systems Inc - Zoom Interview with David Luxton Pt.3
KWESST podcast pt.2 – Executive Chairman David Luxton talks about laser warfare
Business, A.I. and the future of tech: a conversation with PredictMedix's (PMED.V) Kapil Raval
Investor alert: KWESST podcast pt.1 - a freakishly smart pre-IPO military tech company
Last Mile’s (MILE.V) E-scooters are turning into food delivery fleets
Last Mile’s (MILE.V) CEO Max Smith lays out his master plan: Equity Guru podcast pt.2
Last Mile’s (MILE.V) e-scooters are the perfect solution for college kids who don’t give a damn about cars: Equity Guru podcast pt.1 with Max Smith
Equity.Guru podcast: pt. 2 Yield Growth (BOSS.C) CEO Penny White talks about Urban Juve, topicals, mushrooms and more....
Equity.Guru podcast: pt. 1 Yield Growth (BOSS.C) CEO Penny White lays out her master plan
Equity.Guru Podcast: Mistakes were made - Jeanette VanderMarel's happy goodbye to Beleave
A Closer Look: Isracann BioSciences (IPOT.C) on growing pot in the Promised Land
A Closer Look: Ampd Gaming Technologies (AMPD.C) paves the way for Web 3.0
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
The Commercial Edge: Unleash the Power of People
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast